Quote:
Originally Posted by yeti
I think it is only being used for psoriasis in Germany and the UK. Maybe elsewhere in Europe too, but not here. The name of the psoriasis drug is fumaderm. If you do some searches on that you can read some people's experience with it for psoriasis. Side effects, etc. Although the psoriasis dose is higher than the BG-12 trial dose.
My understanding of availability is that the drug would, on average, be available 10 months after the FDA application was submitted. That happend the end of february, so December/January seems to be the target estimate.
In case you can't tell, I've been reading BG-12 stuff like crazy this weekend. If I get my MS diagnosis, I'm almost sold on holding out for BG-12 instead of taking any of the other DMDs.
|
Thanks, As you can see in my signature, I have tried various meds....for extremely short periods of time....but I have had reactions/allergies to them. I did take LDN for the longest time, 9 months, but during that 9 month period I developed 5 more brain lesions....so, my Neuro took me off of it.
I however, continue to think it is a really good med for MS...for a lot of the same reasons BG12 will be. It controls our endorphin production.
I see my Neuro tomorrow, I may ask again if I can take LDN until BG12 is released.
It seems the more studies that are done, the more they are realizing that the DMD's are not working like they first thought.